Global Off-body Wearable Injectors Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Off-body Wearable Injectors will have significant change from previous year. By the most conservative estimates of global Off-body Wearable Injectors market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Off-body Wearable Injectors market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Off-body Wearable Injectors market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Off-body Wearable Injectors, covering the supply chain analysis, impact assessment to the Off-body Wearable Injectors market size growth rate in several scenarios, and the measures to be undertaken by Off-body Wearable Injectors companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Electronical Injectors
Mechanical Injectors
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Immuno-oncology
Diabetes
Cardiovascular Diseases
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Becton, Dickinson and Company
Unilife
Medtronic
Insulet Corporation
Unilife Corporation
Johnson & Johnson
Ypsomed Group
Enable Injections
West Pharmaceutical Services
SteadyMed
CeQur
ScPharmaceuticals
Roche
SteadyMed
Sensile Medical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Off-body Wearable Injectors consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Off-body Wearable Injectors market by identifying its various subsegments.
Focuses on the key global Off-body Wearable Injectors manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Off-body Wearable Injectors with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Off-body Wearable Injectors submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Off-body Wearable Injectors?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Off-body Wearable Injectors Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Off-body Wearable Injectors Consumption 2015-2025
2.1.2 Off-body Wearable Injectors Consumption CAGR by Region
2.2 Off-body Wearable Injectors Segment by Type
2.2.1 Electronical Injectors
2.2.2 Mechanical Injectors
2.2.3 Others
2.3 Off-body Wearable Injectors Consumption by Type
2.3.1 Global Off-body Wearable Injectors Consumption Market Share by Type (2015-2020)
2.3.2 Global Off-body Wearable Injectors Revenue and Market Share by Type (2015-2020)
2.3.3 Global Off-body Wearable Injectors Sale Price by Type (2015-2020)
2.4 Off-body Wearable Injectors Segment by Application
2.4.1 Immuno-oncology
2.4.2 Diabetes
2.4.3 Cardiovascular Diseases
2.4.4 Other
2.5 Off-body Wearable Injectors Consumption by Application
2.5.1 Global Off-body Wearable Injectors Consumption Market Share by Type (2015-2020)
2.5.2 Global Off-body Wearable Injectors Value and Market Share by Type (2015-2020)
2.5.3 Global Off-body Wearable Injectors Sale Price by Type (2015-2020)
3 Global Off-body Wearable Injectors by Company
3.1 Global Off-body Wearable Injectors Sales Market Share by Company
3.1.1 Global Off-body Wearable Injectors Sales by Company (2018-2020)
3.1.2 Global Off-body Wearable Injectors Sales Market Share by Company (2018-2020)
3.2 Global Off-body Wearable Injectors Revenue Market Share by Company
3.2.1 Global Off-body Wearable Injectors Revenue by Company (2018-2020)
3.2.2 Global Off-body Wearable Injectors Revenue Market Share by Company (2018-2020)
3.3 Global Off-body Wearable Injectors Sale Price by Company
3.4 Global Off-body Wearable Injectors Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Off-body Wearable Injectors Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Off-body Wearable Injectors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Off-body Wearable Injectors by Regions
4.1 Off-body Wearable Injectors by Regions
4.2 Americas Off-body Wearable Injectors Consumption Growth
4.3 APAC Off-body Wearable Injectors Consumption Growth
4.4 Europe Off-body Wearable Injectors Consumption Growth
4.5 Middle East & Africa Off-body Wearable Injectors Consumption Growth
5 Americas
5.1 Americas Off-body Wearable Injectors Consumption by Countries
5.1.1 Americas Off-body Wearable Injectors Consumption by Countries (2015-2020)
5.1.2 Americas Off-body Wearable Injectors Value by Countries (2015-2020)
5.2 Americas Off-body Wearable Injectors Consumption by Type
5.3 Americas Off-body Wearable Injectors Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Off-body Wearable Injectors Consumption by Regions
6.1.1 APAC Off-body Wearable Injectors Consumption by Regions (2015-2020)
6.1.2 APAC Off-body Wearable Injectors Value by Regions (2015-2020)
6.2 APAC Off-body Wearable Injectors Consumption by Type
6.3 APAC Off-body Wearable Injectors Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Off-body Wearable Injectors by Countries
7.1.1 Europe Off-body Wearable Injectors Consumption by Countries (2015-2020)
7.1.2 Europe Off-body Wearable Injectors Value by Countries (2015-2020)
7.2 Europe Off-body Wearable Injectors Consumption by Type
7.3 Europe Off-body Wearable Injectors Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Off-body Wearable Injectors by Countries
8.1.1 Middle East & Africa Off-body Wearable Injectors Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Off-body Wearable Injectors Value by Countries (2015-2020)
8.2 Middle East & Africa Off-body Wearable Injectors Consumption by Type
8.3 Middle East & Africa Off-body Wearable Injectors Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Off-body Wearable Injectors Distributors
10.3 Off-body Wearable Injectors Customer
11 Global Off-body Wearable Injectors Market Forecast
11.1 Global Off-body Wearable Injectors Consumption Forecast (2021-2025)
11.2 Global Off-body Wearable Injectors Forecast by Regions
11.2.1 Global Off-body Wearable Injectors Forecast by Regions (2021-2025)
11.2.2 Global Off-body Wearable Injectors Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Off-body Wearable Injectors Forecast by Type
11.8 Global Off-body Wearable Injectors Forecast by Application
12 Key Players Analysis
12.1 Becton, Dickinson and Company
12.1.1 Company Information
12.1.2 Off-body Wearable Injectors Product Offered
12.1.3 Becton, Dickinson and Company Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Becton, Dickinson and Company Latest Developments
12.2 Unilife
12.2.1 Company Information
12.2.2 Off-body Wearable Injectors Product Offered
12.2.3 Unilife Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Unilife Latest Developments
12.3 Medtronic
12.3.1 Company Information
12.3.2 Off-body Wearable Injectors Product Offered
12.3.3 Medtronic Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Medtronic Latest Developments
12.4 Insulet Corporation
12.4.1 Company Information
12.4.2 Off-body Wearable Injectors Product Offered
12.4.3 Insulet Corporation Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Insulet Corporation Latest Developments
12.5 Unilife Corporation
12.5.1 Company Information
12.5.2 Off-body Wearable Injectors Product Offered
12.5.3 Unilife Corporation Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Unilife Corporation Latest Developments
12.6 Johnson & Johnson
12.6.1 Company Information
12.6.2 Off-body Wearable Injectors Product Offered
12.6.3 Johnson & Johnson Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Johnson & Johnson Latest Developments
12.7 Ypsomed Group
12.7.1 Company Information
12.7.2 Off-body Wearable Injectors Product Offered
12.7.3 Ypsomed Group Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Ypsomed Group Latest Developments
12.8 Enable Injections
12.8.1 Company Information
12.8.2 Off-body Wearable Injectors Product Offered
12.8.3 Enable Injections Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Enable Injections Latest Developments
12.9 West Pharmaceutical Services
12.9.1 Company Information
12.9.2 Off-body Wearable Injectors Product Offered
12.9.3 West Pharmaceutical Services Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 West Pharmaceutical Services Latest Developments
12.10 SteadyMed
12.10.1 Company Information
12.10.2 Off-body Wearable Injectors Product Offered
12.10.3 SteadyMed Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 SteadyMed Latest Developments
12.11 CeQur
12.11.1 Company Information
12.11.2 Off-body Wearable Injectors Product Offered
12.11.3 CeQur Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 CeQur Latest Developments
12.12 ScPharmaceuticals
12.12.1 Company Information
12.12.2 Off-body Wearable Injectors Product Offered
12.12.3 ScPharmaceuticals Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 ScPharmaceuticals Latest Developments
12.13 Roche
12.13.1 Company Information
12.13.2 Off-body Wearable Injectors Product Offered
12.13.3 Roche Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Roche Latest Developments
12.14 SteadyMed
12.14.1 Company Information
12.14.2 Off-body Wearable Injectors Product Offered
12.14.3 SteadyMed Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 SteadyMed Latest Developments
12.15 Sensile Medical
12.15.1 Company Information
12.15.2 Off-body Wearable Injectors Product Offered
12.15.3 Sensile Medical Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Sensile Medical Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Off-body Wearable Injectors Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Off-body Wearable Injectors Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Off-body Wearable Injectors Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Electronical Injectors
Table 7. Major Players of Mechanical Injectors
Table 8. Major Players of Others
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Off-body Wearable Injectors Consumption Market Share by Type (2015-2020)
Table 11. Global Off-body Wearable Injectors Revenue by Type (2015-2020) ($ million)
Table 12. Global Off-body Wearable Injectors Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Off-body Wearable Injectors Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Off-body Wearable Injectors Consumption Market Share by Application (2015-2020)
Table 16. Global Off-body Wearable Injectors Value by Application (2015-2020)
Table 17. Global Off-body Wearable Injectors Value Market Share by Application (2015-2020)
Table 18. Global Off-body Wearable Injectors Sale Price by Application (2015-2020)
Table 19. Global Off-body Wearable Injectors Sales by Company (2017-2019) (K Units)
Table 20. Global Off-body Wearable Injectors Sales Market Share by Company (2017-2019)
Table 21. Global Off-body Wearable Injectors Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Off-body Wearable Injectors Revenue Market Share by Company (2017-2019)
Table 23. Global Off-body Wearable Injectors Sale Price by Company (2017-2019)
Table 24. Global Off-body Wearable Injectors Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Off-body Wearable Injectors Products Offered
Table 26. Off-body Wearable Injectors Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Off-body Wearable Injectors Consumption by Regions 2015-2020 (K Units)
Table 28. Global Off-body Wearable Injectors Consumption Market Share by Regions 2015-2020
Table 29. Global Off-body Wearable Injectors Value by Regions 2015-2020 ($ Millions)
Table 30. Global Off-body Wearable Injectors Value Market Share by Regions 2015-2020
Table 31. Americas Off-body Wearable Injectors Consumption by Countries (2015-2020) (K Units)
Table 32. Americas Off-body Wearable Injectors Consumption Market Share by Countries (2015-2020)
Table 33. Americas Off-body Wearable Injectors Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Off-body Wearable Injectors Value Market Share by Countries (2015-2020)
Table 35. Americas Off-body Wearable Injectors Consumption by Type (2015-2020) (K Units)
Table 36. Americas Off-body Wearable Injectors Consumption Market Share by Type (2015-2020)
Table 37. Americas Off-body Wearable Injectors Consumption by Application (2015-2020) (K Units)
Table 38. Americas Off-body Wearable Injectors Consumption Market Share by Application (2015-2020)
Table 39. APAC Off-body Wearable Injectors Consumption by Countries (2015-2020) (K Units)
Table 40. APAC Off-body Wearable Injectors Consumption Market Share by Countries (2015-2020)
Table 41. APAC Off-body Wearable Injectors Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Off-body Wearable Injectors Value Market Share by Regions (2015-2020)
Table 43. APAC Off-body Wearable Injectors Consumption by Type (2015-2020) (K Units)
Table 44. APAC Off-body Wearable Injectors Consumption Market Share by Type (2015-2020)
Table 45. APAC Off-body Wearable Injectors Consumption by Application (2015-2020) (K Units)
Table 46. APAC Off-body Wearable Injectors Consumption Market Share by Application (2015-2020)
Table 47. Europe Off-body Wearable Injectors Consumption by Countries (2015-2020) (K Units)
Table 48. Europe Off-body Wearable Injectors Consumption Market Share by Countries (2015-2020)
Table 49. Europe Off-body Wearable Injectors Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Off-body Wearable Injectors Value Market Share by Countries (2015-2020)
Table 51. Europe Off-body Wearable Injectors Consumption by Type (2015-2020) (K Units)
Table 52. Europe Off-body Wearable Injectors Consumption Market Share by Type (2015-2020)
Table 53. Europe Off-body Wearable Injectors Consumption by Application (2015-2020) (K Units)
Table 54. Europe Off-body Wearable Injectors Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Off-body Wearable Injectors Consumption by Countries (2015-2020) (K Units)
Table 56. Middle East & Africa Off-body Wearable Injectors Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Off-body Wearable Injectors Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Off-body Wearable Injectors Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Off-body Wearable Injectors Consumption by Type (2015-2020) (K Units)
Table 60. Middle East & Africa Off-body Wearable Injectors Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Off-body Wearable Injectors Consumption by Application (2015-2020) (K Units)
Table 62. Middle East & Africa Off-body Wearable Injectors Consumption Market Share by Application (2015-2020)
Table 63. Off-body Wearable Injectors Distributors List
Table 64. Off-body Wearable Injectors Customer List
Table 65. Global Off-body Wearable Injectors Consumption Forecast by Countries (2021-2025) (K Units)
Table 66. Global Off-body Wearable Injectors Consumption Market Forecast by Regions
Table 67. Global Off-body Wearable Injectors Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Off-body Wearable Injectors Value Market Share Forecast by Regions
Table 69. Global Off-body Wearable Injectors Consumption Forecast by Type (2021-2025) (K Units)
Table 70. Global Off-body Wearable Injectors Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Off-body Wearable Injectors Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Off-body Wearable Injectors Value Market Share Forecast by Type (2021-2025)
Table 73. Global Off-body Wearable Injectors Consumption Forecast by Application (2021-2025) (K Units)
Table 74. Global Off-body Wearable Injectors Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Off-body Wearable Injectors Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Off-body Wearable Injectors Value Market Share Forecast by Application (2021-2025)
Table 77. Becton, Dickinson and Company Product Offered
Table 78. Becton, Dickinson and Company Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 79. Becton, Dickinson and Company Main Business
Table 80. Becton, Dickinson and Company Latest Developments
Table 81. Becton, Dickinson and Company Basic Information, Company Total Revenue (in $ million), Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 82. Unilife Product Offered
Table 83. Unilife Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 84. Unilife Main Business
Table 85. Unilife Latest Developments
Table 86. Unilife Basic Information, Company Total Revenue (in $ million), Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 87. Medtronic Product Offered
Table 88. Medtronic Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 89. Medtronic Main Business
Table 90. Medtronic Latest Developments
Table 91. Medtronic Basic Information, Company Total Revenue (in $ million), Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 92. Insulet Corporation Product Offered
Table 93. Insulet Corporation Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 94. Insulet Corporation Main Business
Table 95. Insulet Corporation Latest Developments
Table 96. Insulet Corporation Basic Information, Company Total Revenue (in $ million), Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 97. Unilife Corporation Product Offered
Table 98. Unilife Corporation Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 99. Unilife Corporation Main Business
Table 100. Unilife Corporation Latest Developments
Table 101. Unilife Corporation Basic Information, Company Total Revenue (in $ million), Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 102. Johnson & Johnson Product Offered
Table 103. Johnson & Johnson Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 104. Johnson & Johnson Main Business
Table 105. Johnson & Johnson Latest Developments
Table 106. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 107. Ypsomed Group Product Offered
Table 108. Ypsomed Group Basic Information, Company Total Revenue (in $ million), Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 109. Ypsomed Group Main Business
Table 110. Ypsomed Group Latest Developments
Table 111. Ypsomed Group Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 112. Enable Injections Product Offered
Table 113. Enable Injections Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 114. Enable Injections Main Business
Table 115. Enable Injections Latest Developments
Table 116. Enable Injections Basic Information, Company Total Revenue (in $ million), Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 117. West Pharmaceutical Services Product Offered
Table 118. West Pharmaceutical Services Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 119. West Pharmaceutical Services Main Business
Table 120. West Pharmaceutical Services Latest Developments
Table 121. West Pharmaceutical Services Basic Information, Company Total Revenue (in $ million), Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 122. SteadyMed Product Offered
Table 123. SteadyMed Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 124. SteadyMed Main Business
Table 125. SteadyMed Latest Developments
Table 126. SteadyMed Basic Information, Company Total Revenue (in $ million), Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 127. CeQur Product Offered
Table 128. CeQur Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 129. CeQur Main Business
Table 130. CeQur Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 131. CeQur Latest Developments
Table 132. ScPharmaceuticals Product Offered
Table 133. ScPharmaceuticals Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 134. ScPharmaceuticals Main Business
Table 135. ScPharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 136. ScPharmaceuticals Latest Developments
Table 137. Roche Product Offered
Table 138. Roche Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 139. Roche Main Business
Table 140. Roche Latest Developments
Table 141. Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 142. SteadyMed Product Offered
Table 143. SteadyMed Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 144. SteadyMed Main Business
Table 145. SteadyMed Latest Developments
Table 146. SteadyMed Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 147. Sensile Medical Product Offered
Table 148. Sensile Medical Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 149. Sensile Medical Main Business
Table 150. Sensile Medical Latest Developments
Table 151. Sensile Medical Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Off-body Wearable Injectors
Figure 2. Off-body Wearable Injectors Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Off-body Wearable Injectors Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Off-body Wearable Injectors Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Electronical Injectors
Figure 7. Product Picture of Mechanical Injectors
Figure 8. Product Picture of Others
Figure 9. Global Off-body Wearable Injectors Consumption Market Share by Type (2015-2020)
Figure 10. Global Off-body Wearable Injectors Value Market Share by Type (2015-2020)
Figure 11. Off-body Wearable Injectors Consumed in Immuno-oncology
Figure 12. Global Off-body Wearable Injectors Market: Immuno-oncology (2015-2020) (K Units)
Figure 13. Global Off-body Wearable Injectors Market: Immuno-oncology (2015-2020) ($ Millions)
Figure 14. Off-body Wearable Injectors Consumed in Diabetes
Figure 15. Global Off-body Wearable Injectors Market: Diabetes (2015-2020) (K Units)
Figure 16. Global Off-body Wearable Injectors Market: Diabetes (2015-2020) ($ Millions)
Figure 17. Off-body Wearable Injectors Consumed in Cardiovascular Diseases
Figure 18. Global Off-body Wearable Injectors Market: Cardiovascular Diseases (2015-2020) (K Units)
Figure 19. Global Off-body Wearable Injectors Market: Cardiovascular Diseases (2015-2020) ($ Millions)
Figure 20. Off-body Wearable Injectors Consumed in Other
Figure 21. Global Off-body Wearable Injectors Market: Other (2015-2020) (K Units)
Figure 22. Global Off-body Wearable Injectors Market: Other (2015-2020) ($ Millions)
Figure 23. Global Off-body Wearable Injectors Consumption Market Share by Application (2015-2020)
Figure 24. Global Off-body Wearable Injectors Value Market Share by Application (2015-2020)
Figure 25. Global Off-body Wearable Injectors Sales Market Share by Company in 2017
Figure 26. Global Off-body Wearable Injectors Sales Market Share by Company in 2019
Figure 27. Global Off-body Wearable Injectors Revenue Market Share by Company in 2017
Figure 28. Global Off-body Wearable Injectors Revenue Market Share by Company in 2019
Figure 29. Global Off-body Wearable Injectors Sale Price by Company in 2019
Figure 30. Global Off-body Wearable Injectors Consumption Market Share by Regions 2015-2020
Figure 31. Global Off-body Wearable Injectors Value Market Share by Regions 2015-2020
Figure 32. Americas Off-body Wearable Injectors Consumption 2015-2020 (K Units)
Figure 33. Americas Off-body Wearable Injectors Value 2015-2020 ($ Millions)
Figure 34. APAC Off-body Wearable Injectors Consumption 2015-2020 (K Units)
Figure 35. APAC Off-body Wearable Injectors Value 2015-2020 ($ Millions)
Figure 36. Europe Off-body Wearable Injectors Consumption 2015-2020 (K Units)
Figure 37. Europe Off-body Wearable Injectors Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Off-body Wearable Injectors Consumption 2015-2020 (K Units)
Figure 39. Middle East & Africa Off-body Wearable Injectors Value 2015-2020 ($ Millions)
Figure 40. Americas Off-body Wearable Injectors Consumption Market Share by Countries in 2019
Figure 41. Americas Off-body Wearable Injectors Value Market Share by Countries in 2019
Figure 42. Americas Off-body Wearable Injectors Consumption Market Share by Type in 2019
Figure 43. Americas Off-body Wearable Injectors Consumption Market Share by Application in 2019
Figure 44. United States Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 45. United States Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 47. Canada Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 49. Mexico Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Off-body Wearable Injectors Consumption Market Share by Countries in 2019
Figure 51. APAC Off-body Wearable Injectors Value Market Share by Regions in 2019
Figure 52. APAC Off-body Wearable Injectors Consumption Market Share by Type in 2019
Figure 53. APAC Off-body Wearable Injectors Consumption Market Share by Application in 2019
Figure 54. China Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 55. China Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 57. Japan Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 59. Korea Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 61. Southeast Asia Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 62. India Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 63. India Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 65. Australia Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Off-body Wearable Injectors Consumption Market Share by Countries in 2019
Figure 67. Europe Off-body Wearable Injectors Value Market Share by Countries in 2019
Figure 68. Europe Off-body Wearable Injectors Consumption Market Share by Type in 2019
Figure 69. Europe Off-body Wearable Injectors Consumption Market Share by Application in 2019
Figure 70. Germany Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 71. Germany Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 72. France Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 73. France Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 74. UK Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 75. UK Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 77. Italy Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 79. Russia Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Off-body Wearable Injectors Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Off-body Wearable Injectors Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Off-body Wearable Injectors Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Off-body Wearable Injectors Consumption Market Share by Application in 2019
Figure 84. Egypt Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 85. Egypt Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 87. South Africa Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 89. Israel Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 91. Turkey Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Off-body Wearable Injectors Consumption Growth 2015-2020 (K Units)
Figure 93. GCC Countries Off-body Wearable Injectors Value Growth 2015-2020 ($ Millions)
Figure 94. Global Off-body Wearable Injectors Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 95. Global Off-body Wearable Injectors Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 97. Americas Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 98. APAC Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 99. APAC Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 100. Europe Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 101. Europe Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 103. Middle East & Africa Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 104. United States Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 105. United States Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 106. Canada Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 107. Canada Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 108. Mexico Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 109. Mexico Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 110. Brazil Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 111. Brazil Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 112. China Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 113. China Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 114. Japan Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 115. Japan Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 116. Korea Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 117. Korea Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 118. Southeast Asia Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 119. Southeast Asia Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 120. India Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 121. India Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 122. Australia Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 123. Australia Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 124. Germany Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 125. Germany Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 126. France Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 127. France Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 128. UK Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 129. UK Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 130. Italy Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 131. Italy Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 132. Russia Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 133. Russia Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 134. Spain Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 135. Spain Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 136. Egypt Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 137. Egypt Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 138. South Africa Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 139. South Africa Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 140. Israel Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 141. Israel Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 142. Turkey Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 143. Turkey Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 144. GCC Countries Off-body Wearable Injectors Consumption 2021-2025 (K Units)
Figure 145. GCC Countries Off-body Wearable Injectors Value 2021-2025 ($ Millions)
Figure 146. Becton, Dickinson and Company Off-body Wearable Injectors Market Share (2018-2020)
Figure 147. Unilife Off-body Wearable Injectors Market Share (2018-2020)
Figure 148. Medtronic Off-body Wearable Injectors Market Share (2018-2020)
Figure 149. Insulet Corporation Off-body Wearable Injectors Market Share (2018-2020)
Figure 150. Unilife Corporation Off-body Wearable Injectors Market Share (2018-2020)
Figure 151. Johnson & Johnson Off-body Wearable Injectors Market Share (2018-2020)
Figure 152. Ypsomed Group Off-body Wearable Injectors Market Share (2018-2020)
Figure 153. Enable Injections Off-body Wearable Injectors Market Share (2018-2020)
Figure 154. West Pharmaceutical Services Off-body Wearable Injectors Market Share (2018-2020)
Figure 155. SteadyMed Off-body Wearable Injectors Market Share (2018-2020)
Figure 156. CeQur Off-body Wearable Injectors Market Share (2018-2020)
Figure 157. ScPharmaceuticals Off-body Wearable Injectors Market Share (2018-2020)
Figure 158. Roche Off-body Wearable Injectors Market Share (2018-2020)
Figure 159. SteadyMed Off-body Wearable Injectors Market Share (2018-2020)
Figure 160. Sensile Medical Off-body Wearable Injectors Market Share (2018-2020)
